CASI PHARMACEUTICALS INC - COM (CASI) Institutional Ownership

CUSIP: 14757U109

13F Institutional Holders and Ownership History from Q2 2014 to Q1 2023

Type / Class
Equity / COM
Symbol
CASI on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q1 0 $0 -$629,139 0
2022 Q4 351,474 $629,139 -$21,637 $1.79 3
2022 Q3 363,562 $945,000 +$12,977 $2.60 2
2022 Q2 358,567 $1,026,000 -$25,213,191 $2.86 2
2022 Q1 23,306,553 $18,884,089 -$3,721,274 $0.81 36
2021 Q4 27,963,285 $22,368,076 -$3,392,072 $0.80 46
2021 Q3 38,670,498 $46,019,210 -$9,795,208 $1.19 55
2021 Q2 46,671,130 $72,329,878 -$13,539,472 $1.55 65
2021 Q1 53,077,474 $127,388,870 +$27,900,830 $2.40 80
2020 Q4 41,424,694 $122,202,721 +$5,597,299 $2.95 68
2020 Q3 39,599,236 $60,588,863 +$25,462,661 $1.53 64
2020 Q2 22,878,667 $57,193,612 +$2,915,666 $2.50 56
2020 Q1 21,739,166 $44,345,565 +$2,549,424 $2.04 55
2019 Q4 20,437,523 $63,151,654 +$4,853,188 $3.09 49
2019 Q3 10,894,078 $36,384,713 -$2,370,012 $3.34 50
2019 Q2 11,652,206 $37,283,720 +$1,402,976 $3.20 48
2019 Q1 11,475,709 $32,933,759 -$53,260 $2.87 51
2018 Q4 11,417,745 $45,896,953 +$2,570,804 $4.02 50
2018 Q3 10,748,223 $50,195,309 +$4,023,678 $4.67 56
2018 Q2 9,816,931 $80,787,402 +$41,718,111 $8.23 52
2018 Q1 4,970,323 $20,728,000 +$5,675,403 $4.17 36
2017 Q4 3,623,662 $11,777,000 +$4,073,224 $3.25 30
2017 Q3 2,388,403 $4,231,000 +$186,322 $1.77 19
2017 Q2 2,297,879 $2,413,000 -$60,889 $1.05 18
2017 Q1 2,341,993 $3,324,000 +$578,948 $1.42 17
2016 Q4 2,217,476 $2,549,000 +$20,507 $1.15 20
2016 Q3 2,206,008 $2,448,000 +$18,682 $1.11 23
2016 Q2 2,185,988 $2,561,000 +$35,327 $1.17 21
2016 Q1 2,157,351 $2,286,000 +$167,329 $1.06 20
2015 Q4 2,001,529 $1,921,000 -$419,303 $0.96 20
2015 Q3 2,423,573 $2,592,000 +$303,481 $1.07 23
2015 Q2 2,139,560 $3,834,233 -$34,339 $1.79 21
2015 Q1 2,159,630 $3,206,192 -$1,106,947 $1.48 21
2014 Q4 2,993,802 $4,027,053 -$304,187 $1.33 23
2014 Q3 3,215,798 $5,760,072 +$2,689,171 $1.79 21
2014 Q2 1,715,400 $3,087,000 +$3,087,000 $1.80 5